Avanir Pharma (AVNR) – Analyst Ratings
-
Roth Remains Positive on Concert Pharma (CNCE) Amid Upcoming AVP-786 Phase 3s (AVNR)
-
Cowen Downgrades Avanir Pharmaceuticals (AVNR) to Market Perform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AVNR Stock Lookup